TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/07 16:17 | 9/5/07 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Thompson John D | CA | O | SVP,Corp | S.ad | -2,225 | 80.00 | 0 | -28 | -81 | 7 | D | ||||||||||||||
9/7/07 14:24 | 9/5/07 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Thompson John D | CA | O | SVP,Corp | S.d | -2,225 | 80.00 | 0 | -28 | -81 | 7 | D | ||||||||||||||
8/3/05 21:17 | 8/1/05 | IVGN | Willy Co | Fund | CEF | Closed-End Funds | Thompson John D | CA | O | SVP,Corp | S.dm | -4,950 | 66.00 | 0 | -75 | -95 | 4 | D | |||||||||||||||
8/3/05 21:11 | 8/1/05 | IVGN | Willy Co | Fund | CEF | Closed-End Funds | Thompson John D | CA | O | SVP,Corp | S.dm | -4,950 | 66.00 | 0 | -75 | -95 | 4 | D | |||||||||||||||
2/19/04 11:23 | 2/17/04 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Thompson John D | CA | O | SVP Corp | S.d | -1,916 | 76.63 | 0 | -25 | -89 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |